Raymond James Maintains Outperform on Guardant Health, Raises Price Target to $61

Benzinga · 07/31 14:28
Raymond James analyst Andrew Cooper maintains Guardant Health (NASDAQ:GH) with a Outperform and raises the price target from $59 to $61.